Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies

Microbes and Infection

Volumn 8, Issue 7, 2006, Pages 1937-1944

  Giraud, Etienne ^a   Baucheron, Sylvie ^b   Cloeckaert, Axel ^b  

^a LUNAM UNIVERSITÉ   (France)

^b CEMAGREF   (France)

Author keywords

Fluoroquinolones; Resistance; Salmonella

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; DNA TOPOISOMERASE; ENROFLOXACIN; LEVOFLOXACIN; MARBOFLOXACIN; NALIDIXIC ACID; NAPHTHYL GROUP; PHENYLALANYLARGININE BETA NAPHTHYLAMIDE; QNR PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; BACTERIAL GENETICS; BACTERIAL STRAIN; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; MUTAGENESIS; NONHUMAN; PLASMID; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; SHORT SURVEY; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL;

SALMONELLA;

EID: 33746632141     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.12.025     Document Type: Short Survey

References (71)

1. Angulo F.J., Johnson K.R., Tauxe R.V., and Cohen M.L. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb. Drug Resist. 6 (2000) 77-83
2. Chiu C.H., Su L.H., Chu C., Chia J.H., Wu T.L., Lin T.Y., et al. Isolation of Salmonella enterica serotype Choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 363 (2004) 1285-1286
3. Velge P., Cloeckaert A., and Barrow P. Emergence of Salmonella epidemics: the problems related to Salmonella enterica serotype Enteritidis and multiple antibiotic resistance in other major serotypes. Vet. Res. 36 (2005) 267-288
4. Giraud E., Cloeckaert A., Baucheron S., Mouline C., and Chaslus-Dancla E. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J. Med. Microbiol. 52 (2003) 697-703
5. Giraud E., Brisabois A., Martel J.L., and Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43 (1999) 2131-2137
6. Olsen S.J., DeBess E.E., McGivern T.E., Marano N., Eby T., Mauvais S., et al. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N. Engl. J. Med. 344 (2001) 1572-1579
7. Nakaya H., Yasuhara A., Yoshimura K., Oshihoi Y., Izumiya H., and Watanabe H. Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica Typhimurium with mutations in both gyrA and parC. Emerg. Infect. Dis. 9 (2003) 255-257
8. Ling J.M., Chan E.W., Lam A.W., and Cheng A.F. Mutations in topoisomerase genes of fluoroquinolone-resistant Salmonellae in Hong Kong. Antimicrob. Agents Chemother. 47 (2003) 3567-3573
9. Huang T.M., Chang Y.F., and Chang C.F. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan. Vet. Microbiol. 100 (2004) 247-254
10. Hsueh P.R., Teng L.J., Tseng S.P., Chang C.F., Wan J.H., Yan J.J., et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg. Infect. Dis. 10 (2004) 60-68
11. Casin I., Breuil J., Darchis J.P., Guelpa C., and Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica Typhimurium isolates in humans. Emerg. Infect. Dis. 9 (2003) 1455-1457
12. Chu C., Su L.H., Chu C.H., Baucheron S., Cloeckaert A., and Chiu C.H. Resistance to fluoroquinolones linked to gyrA and parC mutations and overexpression of acrAB efflux pump in Salmonella enterica serotype Choleraesuis. Microb. Drug Resist. 11 (2005) 248-253
13. Izumiya H., Mori K., Kurazono T., Yamaguchi M., Higashide M., Konishi N., et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. J. Clin. Microbiol. 43 (2005) 5074-5079
14. Cheung T.K., Chu Y.W., Chu M.Y., Ma C.H., Yung R.W., and Kam K.M. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J. Antimicrob. Chemother. 56 (2005) 586-589
15. Hopkins K.L., Davies R.H., and Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 25 (2005) 358-373
16. Wiuff C., Madsen M., Baggesen D.L., and Aarestrup F.M. Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark. Microb. Drug Resist. 6 (2000) 11-17
17. Hirose K., Hashimoto A., Tamura K., Kawamura Y., Ezaki T., Sagara H., et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob. Agents Chemother. 46 (2002) 3249-3252
18. Eaves D.J., Liebana E., Woodward M.J., and Piddock L.J. Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J. Clin. Microbiol. 40 (2002) 4121-4125
19. Walker R.A., Saunders N., Lawson A.J., Lindsay E.A., Dassama M., Ward L.R., et al. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J. Clin. Microbiol. 39 (2001) 1443-1448
20. Levy D.D., Sharma B., and Cebula T.A. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype. Antimicrob. Agents Chemother. 48 (2004) 2355-2363
21. Allen K.J., and Poppe C. Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin. Microb. Drug Resist. 8 (2002) 375-383
22. Heisig P., Kratz B., Halle E., Graser Y., Altwegg M., Rabsch W., et al. Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella Typhimurium from men and cattle in Germany. Microb. Drug Resist. 1 (1995) 211-218
23. Baucheron S., Chaslus-Dancla E., Cloeckaert A., Chiu C.H., and Butaye P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob. Agents Chemother. 49 (2005) 862-863
24. Reyna F., Huesca M., Gonzalez V., and Fuchs L.Y. Salmonella Typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39 (1995) 1621-1623
25. Eaves D.J., Randall L., Gray D.T., Buckley A., Woodward M.J., White A.P., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob. Agents Chemother. 48 (2004) 4012-4015
26. Griggs D.J., Gensberg K., and Piddock L.J. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob. Agents Chemother. 40 (1996) 1009-1013
27. Ridley A., and Threlfall E.J. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella Typhimurium DT 104. Microb. Drug Resist. 4 (1998) 113-118
28. Guerra B., Malorny B., Schroeter A., and Helmuth R. Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany. Antimicrob. Agents Chemother. 47 (2003) 2059
29. Baucheron S., Imberechts H., Chaslus-Dancla E., and Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8 (2002) 281-289
30. Gensberg K., Jin Y.F., and Piddock L.J. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella Typhimurium. FEMS Microbiol. Lett. 132 (1995) 57-60
31. Hansen H., and Heisig P. Topoisomerase IV mutations in quinolone-resistant Salmonellae selected in vitro. Microb. Drug Resist. 9 (2003) 25-32
32. Giraud E., Cloeckaert A., Kerboeuf D., and Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44 (2000) 1223-1228
33. Baucheron S., Tyler S., Boyd D., Mulvey M.R., Chaslus-Dancla E., and Cloeckaert A. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob. Agents Chemother. 48 (2004) 3729-3735
34. Baucheron S., Chaslus-Dancla E., and Cloeckaert A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J. Antimicrob. Chemother. 53 (2004) 657-659
35. Olliver A., Valle M., Chaslus-Dancla E., and Cloeckaert A. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob. Agents Chemother. 49 (2005) 289-301
36. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45 (2001) 105-116
37. Okusu H., Ma D., and Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178 (1996) 306-308
38. Randall L.P., and Woodward M.J. The multiple antibiotic resistance (mar) locus and its significance. Res. Vet. Sci. 72 (2002) 87-93
39. White D.G., Goldman J.D., Demple B., and Levy S.B. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J. Bacteriol. 179 (1997) 6122-6126
40. Sulavik M.C., Dazer M., and Miller P.F. The Salmonella Typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J. Bacteriol. 179 (1997) 1857-1866
41. Olliver A., Valle M., Chaslus-Dancla E., and Cloeckaert A. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol. Lett. 238 (2004) 267-272
42. Koutsolioutsou A., Martins E.A., White D.G., Levy S.B., and Demple B. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium). Antimicrob. Agents Chemother. 45 (2001) 38-43
43. Eaves D.J., Ricci V., and Piddock L.J. Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob. Agents Chemother. 48 (2004) 1145-1150
44. Chiu C.H., Tang P., Chu C., Hu S., Bao Q., Yu J., et al. The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res. 33 (2005) 1690-1698
45. Kobayashi K., Tsukagoshi N., and Aono R. Suppression of hypersensitivity of Escherichia coli acrB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element. J. Bacteriol. 183 (2001) 2646-2653
46. Jellen-Ritter A.S., and Kern W.V. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob. Agents Chemother. 45 (2001) 1467-1472
47. Yassien M.A., Ewis H.E., Lu C.D., and Abdelal A.T. Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma Gene, which confers multiple drug resistance in Escherichia coli. Antimicrob. Agents Chemother. 46 (2002) 360-366
48. van der Straaten T., Janssen R., Mevius D.J., and van Dissel J.T. Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 48 (2004) 2292-2294
49. Nordmann P., and Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56 (2005) 463-469
50. Martinez-Martinez L., Pascual A., and Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 351 (1998) 797-799
51. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5638-5642
52. Tran J.H., Jacoby G.A., and Hooper D.C. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49 (2005) 118-125
53. Tran J.H., Jacoby G.A., and Hooper D.C. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother. 49 (2005) 3050-3052
54. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (2000), National Committee for Clinical Laboratory Standards, Wayne, PA Approved standards M7-A5
55. Members of the SFM Antibiogram Committee. Comité de l'Antibiogramme de la Société Française de Microbiologie. Report 2003. Int. J. Antimicrob. Agents 21 (2003) 364-391
56. Li X.Z. Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms. Int. J. Antimicrob. Agents 25 (2005) 453-463
57. Kern W.V., Oethinger M., Jellen-Ritter A.S., and Levy S.B. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 44 (2000) 814-820
58. Drlica K. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52 (2003) 11-17
59. Martinez J.L., and Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44 (2000) 1771-1777
60. Cirz R.T., Chin J.K., Andes D.R., de Crecy-Lagard V., Craig W.A., and Romesberg F.E. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3 (2005) e176
61. Lomovskaya O., and Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3 (2001) 225-236
62. Hooper D.C. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31 Suppl. 2 (2000) S24-S28
63. Toutain P.L. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. AAPS PharmSci. 4 (2002) E38
64. Wise R. Maximizing efficacy and reducing the emergence of resistance. J. Antimicrob. Chemother. 51 Suppl. 1 (2003) 37-42
65. Randall L.P., Cooles S.W., Piddock L.J., and Woodward M.J. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica. J. Antimicrob. Chemother. 54 (2004) 688-691
66. Aarestrup F.M., Wiuff C., Molbak K., and Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.?. Antimicrob. Agents Chemother. 47 (2003) 827-829
67. Wiuff C., Lykkesfeldt J., Svendsen O., and Aarestrup F.M. The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Res. Vet. Sci. 75 (2003) 185-193
68. Bethell D.B., Hien T.T., Phi L.T., Day N.P., Vinh H., Duong N.M., et al. Effects on growth of single short courses of fluoroquinolones. Arch. Dis. Child. 74 (1996) 44-46
69. Zhao X., and Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin. Infect. Dis. 33 Suppl. 3 (2001) S147-S156
70. Markham P.N. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrob. Agents Chemother. 43 (1999) 988-989
71. Riesenfeld C., Everett M., Piddock L.J., and Hall B.G. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob. Agents Chemother. 41 (1997) 2059-2060